Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

Centralized Pan-Algerian Survey on the undertreatment of hypercholesterolemia. The purpose of this study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines in the survey population.

Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia.

Inclusion Criteria:

• Subject must provide informed consent and comply with the survey procedures.
• Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Exclusion Criteria:

- Subjects who are unwilling or unable to provide informed consent.